US Patent

US11554112 — Combinations of β-lactam compounds and probenecid and uses thereof

Method of Use · Assigned to Herum Therapeutics International Ltd · Expires 2039-04-01 · 13y remaining

Vulnerability score 75/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects combinations of beta-lactam compounds and probenecid, and methods of treating or preventing a disease using these combinations.

USPTO Abstract

The present disclosure relates to combinations of a β-lactam compound or a pharmaceutically acceptable salt thereof and probenecid or a pharmaceutically acceptable salt thereof. The present disclosure also relates to methods of treating or preventing a disease via administering to subjects in need thereof a β-lactam compound or a pharmaceutically acceptable salt thereof and probenecid or a pharmaceutically acceptable salt thereof.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

CodeDescriptionDrug
U-4026 — Col-Probenecid

Patent Metadata

Patent number
US11554112
Jurisdiction
US
Classification
Method of Use
Expires
2039-04-01
Drug substance claim
No
Drug product claim
No
Assignee
Herum Therapeutics International Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.